Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnosing alpha 1-antitrypsin deficiency.

J Banasik1

  • 1Washington State University, College of Nursing, Spokane, USA.

The Nurse Practitioner
|February 24, 2001
PubMed
Summary

Alpha 1-antitrypsin deficiency is a genetic disorder increasing emphysema and liver disease risk. Early diagnosis via simple tests allows prevention through lifestyle changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep disturbance and disease activity in adult patients with inflammatory bowel diseases.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018
Same author

Determining AACN's research priorities for the 90s.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·1993
See all related articles

Area of Science:

  • Genetics and Genetic Diseases
  • Pulmonology
  • Hepatology

Background:

  • Alpha 1-antitrypsin deficiency is an inherited condition linked to lung and liver issues.
  • It disproportionately affects individuals of Northern European descent.
  • A significant number of cases remain undiagnosed or misdiagnosed.

Purpose of the Study:

  • To review the epidemiology, genetics, and clinical presentation of Alpha 1-antitrypsin deficiency.
  • To highlight the importance of early diagnosis and prevention strategies.

Main Methods:

  • Review of existing literature on Alpha 1-antitrypsin deficiency.
  • Analysis of epidemiological data and genetic transmission patterns.
  • Description of clinical manifestations and diagnostic approaches.

Main Results:

  • The disorder affects an estimated 70,000-100,000 people in the US.
  • Screening and diagnostic laboratory tests are accessible and cost-effective.
  • Early identification offers a window for preventive interventions.

Conclusions:

  • Alpha 1-antitrypsin deficiency requires greater awareness and improved diagnostic rates.
  • Simple laboratory tests can facilitate early detection.
  • Patient education on avoiding lung and liver damaging cofactors is crucial for disease prevention.

Related Experiment Videos